Blueprint Medicines Corporation (BPMC) Insider Transactions

56.29 ↑0.93 (1.68%)

As of Market Close on May 27th, 2022.

Insider Transactions

Transaction Date	Owner	Role	Action	Price	Total	Shares Remaining	Price Since	Source
2021-06-28	Kate Haviland	COO	Sold 1 Shares	$90.24	$90	54	-37.62%	Link
2021-05-17	Ariel Hurley	Insider	Sold 3 Shares	$95	$285	0	-40.75%	Link
2021-05-12	Jeffrey W Albers	CEO	Sold 25 Shares	$92.69	$2,317	179	-39.27%	Link
2021-01-04	George Demetri	Director	Sold 758 Shares	$112.15	$85,010	3	-49.81%	Link
2020-12-24	Mark Alan Goldberg	Director	Sold 5 Shares	$125	$625	9	-54.97%	Link
2020-12-17	Charles A Rowland Jr	Director	Sold 10 Shares	$117.82	$1,178	14	-52.22%	Link
2020-12-01	Mark Alan Goldberg	Director	Sold 5 Shares	$110	$550	9	-48.83%	Link
2020-11-03	Christina Rossi	Insider	Sold 345 Shares	$99.69	$34,393	20	-43.53%	Link
2020-10-16	Kate Haviland	COO	Sold 13 Shares	$101.23	$1,316	56	-44.39%	Link
2020-10-07	Ariel Hurley	Insider	Sold 600 Shares	$100	$60,000	10	-43.71%	Link
2020-10-07	Mark Alan Goldberg	Director	Sold 5 Shares	$100	$500	9	-43.71%	Link
2020-10-07	Jeffrey W Albers	CEO	Sold 5 Shares	$99.17	$496	146	-43.24%	Link
2020-09-22	Kate Haviland	COO	Sold 3 Shares	$85.49	$256	45	-34.16%	Link
2020-09-22	George Demetri	Director	Sold 1 Shares	$85	$85	4	-33.78%	Link
2020-09-22	Anthony L Boral	Insider	Sold 6 Shares	$82.33	$494	25	-31.63%	Link
2020-09-17	Nicholas Lydon	Director	Sold 500 Shares	$80	$40,000	47	-29.64%	Link
2020-09-17	Anthony L Boral	Insider	Sold 23 Shares	$80	$1,840	28	-29.64%	Link
2020-08-17	Ariel Hurley	Insider	Sold 700 Shares	$75	$52,500	10	-24.95%	Link